Unusual 11 Mid-Day Movers 10/28: (GRVY) (VRTS) (ITGR) Higher; (OPXA) (SNMX) (STON) Lower
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Opexa Therapeutics (Nasdaq: OPXA) 66.2% LOWER; announced that the Phase 2b Abili-T clinical trial designed to evaluate the efficacy and safety of Tcelna (imilecleucel-T) in patients with secondary progressive multiple sclerosis (SPMS) did not meet its primary endpoint of reduction in brain volume change (atrophy), nor did it meet the secondary endpoint of reduction of the rate of sustained disease progression. Tcelna did show a favorable safety and tolerability profile.
Senomyx (Nasdaq: SNMX) 47.6% LOWER; reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.02 million versus the consensus estimate of $5.36 million.
StoneMor Partners L.P. (NYSE: STON) 43.8% LOWER; announced a quarterly cash distribution of $0.33 per common unit for the 3rd quarter 2016. This represents a reduction of 50% from the prior year 3rd quarter.
eHealth (Nasdaq: EHTH) 39.8% LOWER; reported Q3 EPS of ($0.20), $0.15 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $32.1 million versus the consensus estimate of $36.02 million.
Virtus Investment Partners (Nasdaq: VRTS) 24.5% HIGHER; reported Q3 EPS of $1.64, $0.16 better than the analyst estimate of $1.48. Revenue for the quarter came in at $82.3 million versus the consensus estimate of $80.77 million.
McKesson (NYSE: MCK) 24.1% LOWER; reported Q2 EPS of $2.94, $0.11 worse than the analyst estimate of $3.05. Revenue for the quarter came in at $50 billion versus the consensus estimate of $51.21 billion. McKesson sees FY2017 EPS of $12.35-$12.85, versus the consensus of $13.59.
Integer Holdings Corp (NYSE: ITGR) 23.6% HIGHER; reported Q3 EPS of $0.83, $0.04 better than the analyst estimate of $0.79. Revenue for the quarter came in at $346.6 million versus the consensus estimate of $347.92 million.
AtriCure (Nasdaq: ATRC) 20.1% HIGHER; reported Q3 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $37.85 million.
Cytokinetics, Inc. (Nasdaq: CYTK) 19.4% HIGHER; reported total revenues for the third quarter of 2016 were $59.0 million, compared to $7.9 million, during the same period in 2015. The net income for the third quarter was $31.9 million, or $0.80 and $0.74 per basic and diluted share, respectively. This is compared to the net loss for the same period in 2015 of $(8.8) million, or $(0.23) per basic and diluted share.
Data I/o Corp (Nasdaq: DAIO) 18.2% HIGHER; reported Q3 EPS of $0.08, versus $0.00 reported last year. Revenue for the quarter came in at $6.6 million, versus $0 reported last year.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 01/20: (SWKS) (EMES) (CF) Higher; (PSTI) (AFMD) (BMY) Lower (more...)
- Pre-Open Stock Movers 01/18: (CLCD) (SHLO) (JAZZ) Higher; (GIMO) (TGT) (CSX) Lower (more...)
- Puts with increasing volatility movement and volume: WBA RAD TDG
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesUnusual 11 Mid-Day Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!